StonvexLoading…
StonvexStonvexStonvexCore line items from PHOE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 |
|---|---|---|---|
Revenue | $7.37M | $5.76M | $2.23M |
Operating Income | $1.30M | $1.23M | $376.78K |
Net Income | $1.03M | $1.06M | $351.06K |
EPS (Diluted) | $0.06 | $0.07 | $0.02 |
Total Assets | $5.37M | $3.70M | Not available |
Total Liabilities | $2.26M | $2.00M | Not available |
Cash & Equivalents | $2.38M | $890.58K | Not available |
Free Cash Flow OCF − CapEx | $1.14M | Not available | $-79.72K |
Shares Outstanding | 20.00M | 16.10M | 16.10M |